NAD+ 50mg — Vial Spec, Reconstitution Math & COA

Overview: What Does a 50mg NAD+ Research Vial Contain?

A 50mg NAD+ research vial contains exactly 50 milligrams of highly purified, lyophilized β-Nicotinamide Adenine Dinucleotide powder, synthesized for in vitro testing and preclinical laboratory applications. This specific unit size is engineered for research teams conducting micro-scale enzymatic assays, pilot dose-titration protocols, or short-term primary cell culture studies where minimizing reagent storage duration is critical to preventing aqueous hydrolysis.

Investigators who require lower volumetric throughput often select the 50mg format to ensure that stock solutions are consumed rapidly, avoiding the degradation associated with prolonged liquid storage. If your experimental workflow involves automated liquid handlers, high-throughput microplate screens, or extended animal model studies, scaling up to larger fill sizes—such as our standard NAD+ 100mg vial—may offer greater operational efficiency. Additional vial sizes, coenzymes, and specialized reagents can be explored within our broader catalog of research peptides and biochemicals.

Biochemical Profile and Mechanism of Action in Preclinical Models

Nicotinamide Adenine Dinucleotide is a foundational coenzyme present in all living cells, existing in oxidized (NAD+) and reduced (NADH) forms. In biochemical assays, NAD+ acts as a critical electron acceptor during glycolysis, the beta-oxidation of fatty acids, and the tricarboxylic acid (TCA) cycle. Beyond its primary role in mitochondrial oxidative phosphorylation, NAD+ operates as an essential substrate for several families of regulatory enzymes.

Preclinical studies indicate that NAD+ is consumed as a co-substrate by sirtuins (SIRT1–SIRT7), a class of NAD+-dependent deacetylases involved in chromatin remodeling, mitochondrial biogenesis, and cellular stress response pathways. Additionally, in vitro data demonstrate that poly(ADP-ribose) polymerases (PARPs) rely on NAD+ to synthesize poly(ADP-ribose) chains during DNA damage repair mechanisms. Because these enzymatic pathways cleave the glycosidic bond of NAD+, constant replenishment of the dinucleotide pool is necessary to maintain bioenergetic signaling in experimental cell models.

Reconstitution Mathematics for 50mg NAD+ Vials

Accurate reconstitution of a 50mg lyophilized NAD+ vial requires accounting for both mass and molar concentrations. The molecular weight of β-Nicotinamide Adenine Dinucleotide free acid is approximately 663.43 g/mol. Reconstitution should be performed using sterile, cold bacteristatic water, sterile phosphate-buffered saline (PBS, pH 7.2–7.4), or nuclease-free water, depending on downstream assay parameters.

Below are the calculated concentrations for standard reconstitution diluent volumes added to a 50mg vial:

• 1.0 mL Diluent Addition: Yields a concentration of 50.0 mg/mL (75.36 mM). This high-density stock is ideal for serial dilutions in microplate enzymatic assays where minimal liquid volume addition is required.

• 2.0 mL Diluent Addition: Yields a concentration of 25.0 mg/mL (37.68 mM). This intermediate concentration provides an optimal volumetric range for standard multi-channel pipetting and benchtop handling.

• 3.0 mL Diluent Addition: Yields a concentration of 16.67 mg/mL (25.12 mM). Suitable for large-volume working solutions where pipetting larger volumes reduces percentage volumetric error.

For custom volumetric adjustments or mixed-compound molarity calculations, researchers are encouraged to utilize the interactive PX1 reconstitution calculator to streamline lab preparation.

Aliquot Planning and Freeze-Thaw Degradation Mitigation

In aqueous solution, NAD+ is inherently prone to spontaneous non-enzymatic hydrolysis, breaking down into nicotinamide and ADP-ribose. The rate of degradation increases exponentially at ambient temperatures or under alkaline conditions. Consequently, reconstituting a 50mg vial into a single working vessel and repeatedly accessing it at room temperature will compromise experimental reproducibility.

To preserve structural integrity, investigators should establish a immediate aliquot plan upon diluent addition. The reconstituted solution should be divided into single-use micro-aliquots (e.g., 50 µL to 200 µL) in sterile, polypropylene microcentrifuge tubes. Aliquots must be flash-frozen using liquid nitrogen or a dry ice/ethanol bath and stored immediately at -80°C. Micro-aliquots should be thawed only once directly prior to assay execution, discarding any unused remaining volume.

Quality Assurance: HPLC, MS, and Endotoxin Verification

PX1 Research enforces rigorous quality control parameters for every manufactured lot of NAD+. Every batch undergoes high-performance liquid chromatography (HPLC) to verify chemical purity, ensuring that total organic impurities and degradation products do not exceed strict analytical limits.

Mass spectrometry (LC-MS) is simultaneously performed to confirm identity, verifying the characteristic mass-to-charge ratio ($m/z = 664.1$ $[M+H]^+$) of the active coenzyme molecule. Furthermore, because cell culture models are sensitive to bacterial contaminants, each lot undergoes Chromogenic LAL testing to guarantee endotoxin levels remain below 0.05 EU/mg. Researchers can review, print, and archive lot-matched documentation directly through our centralized COA verification portal.

Storage Conditions and Lyophilized Stability Protocols

Maintaining proper thermal control is critical to extending the shelf life of NAD+ compounds. Lyophilized 50mg vials must be stored in a dark, dry environment at -20°C or colder upon receipt. Under these desiccated conditions, the lyophilized powder maintains baseline stability for up to 24 months.

Once reconstituted into an aqueous phase, the stability window narrows significantly. At 4°C, aqueous NAD+ solutions experience measurable degradation within 48 to 72 hours. At -20°C, reconstituted stock solutions remain stable for up to 30 days, whereas storage at -80°C preserves biochemical activity for up to 90 days, provided the samples do not undergo freeze-thaw cycles. Vials should always be kept sealed within desiccated packaging prior to reconstitution to prevent moisture uptake.

Comparative Analysis: NAD+ vs. Related Mitochondrial Compounds

In preclinical metabolic research, NAD+ is frequently evaluated alongside other energy-pathway modulators and mitochondrial-targeted peptides. Selecting the appropriate research compound depends on whether the experiment target is direct coenzyme replenishment, mitochondrial structural modulation, or peptide signaling.

While NAD+ acts directly as an enzymatic co-substrate for redox reactions and sirtuin activation, compounds such as NMN serve as immediate biosynthetic precursors within the salvage pathway. In contrast, mitochondrial-derived peptides like MOTS-c function by regulating nuclear gene expression and metabolic homeostasis during cellular stress. Similarly, cell-permeable peptides like SS-31 target inner mitochondrial membrane cardiolipin to optimize electron transport efficiency without altering dinucleotide pool concentrations. Researchers can cross-reference these biochemical mechanisms within our comprehensive preclinical research library.

Vial Size Selection: Evaluating 50mg vs. High-Yield Formulations

Choosing between a 50mg vial and larger mass configurations depends primarily on daily assay consumption and experimental duration. The 50mg vial is optimized for low-volume, high-precision assays where long-term aqueous storage of reconstituted solutions is undesirable.

For research facilities conducting high-throughput screening, continuous cell culture passaging, or multi-week preclinical animal models, small vial sizes may lead to excessive packaging overhead and frequent batch transitions. In such scenarios, ordering high-yield configurations or establishing bulk supply channels via PX1 wholesale accounts ensures batch consistency across large experimental datasets while optimizing lab reagent budgets.

Experimental Protocols in In Vitro and Preclinical Models

In vitro models utilizing exogenous NAD+ often investigate cellular uptake dynamics, intracellular pool replenishment, and downstream target activation. Preclinical studies suggest that incubation of primary cell cultures with NAD+ influences intracellular NAD+/NADH ratios, altering mitochondrial membrane potential and glycolytic flux.

In enzymatic assay setups, purified NAD+ is introduced as a rate-limiting cofactor to measure the kinetic parameters ($K_m$, $V_{max}$) of recombinant sirtuins or CD38 enzymes. During spectrophotometric assays, the reduction of NAD+ to NADH is monitored in real-time by tracking absorbance changes at 340 nm. Precise control of initial NAD+ concentration—made simple by standard 50mg reconstitution protocols—is essential for accurate kinetic modeling.